SMTL ID : 7rvv.1

Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI22

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.00 Å

Oligo State

monomer

Ligands

1 x 7Y2: N-[(benzyloxy)carbonyl]-2-methyl-L-alanyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-4-methyl-L-leucinamide(Covalent)

7Y2.1: 15 residues within 4Å: Chain A: M.49, F.140, L.141, C.145, H.163, H.164, M.165, E.166, H.172, D.187, R.188, Q.189, T.190, A.191, Q.192 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:M.165 Hydrogen bonds: A:C.145, A:H.164, A:E.166, A:E.166, A:E.166

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ma, Y. et al., A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals. Eur.J.Med.Chem. (2022)

Release Date

2022-07-20

Peptides

3C-like proteinase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

3C-like proteinase

Related Entries With Identical Sequence